A family of compounds has recently been developed that may slow the progression of Parkinson's disease. Parkinson's affects both men and women and usually develops after the age of 50. It is one of the most prevalent neurodegenerative diseases, which results from the death of dopamine neurons, eventually leading to rigidity, tremors, and difficulty moving. There are existing medications that can alleviate the symptoms, but unfortunately they do not have an impact on the development of the disease. The new compounds were developed by Richard B...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment